SVCM
Saturn V Capital Management Portfolio holdings
AUM
$247M
This Quarter Return
+12.73%
1 Year Return
+2.68%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$180M
AUM Growth
+$180M
(+35%)
Cap. Flow
+$28.3M
Cap. Flow
% of AUM
15.71%
Top 10 Holdings %
Top 10 Hldgs %
72.12%
Holding
23
New
5
Increased
9
Reduced
5
Closed
3
Top Buys
| 1 |
Cogent Biosciences
COGT
|
$13.5M |
| 2 |
BioMarin Pharmaceuticals
BMRN
|
$8.03M |
| 3 |
Sarepta Therapeutics
SRPT
|
$6.18M |
| 4 |
Astria Therapeutics
ATXS
|
$4.47M |
| 5 |
Cytokinetics
CYTK
|
$4.02M |
Top Sells
| 1 |
MORF
Morphic Holding, Inc. Common Stock
MORF
|
$5.4M |
| 2 |
CBAY
Cymabay Therapeutics
CBAY
|
$4.84M |
| 3 |
SAGE
Sage Therapeutics
SAGE
|
$3.5M |
| 4 |
Amicus Therapeutics
FOLD
|
$2.86M |
| 5 |
Arcutis Biotherapeutics
ARQT
|
$1.96M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
KDNY
1
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $20.2M | 11.18% | 524,811 +17,993 | +4% | +$691K |
|
2
Crinetics Pharmaceuticals
CRNX
$2.92B
| $16.9M | 9.38% | 938,677 +197,634 | +27% | +$3.56M |
|
|
3
Cogent Biosciences
COGT
$1.69B
| $13.5M | 7.51% | +1,143,368 | New | +$13.5M |
|
|
4
Cytokinetics
CYTK
$4.23B
| $13.3M | 7.35% | 406,225 +123,339 | +44% | +$4.02M |
|
|
CBAY
5
DELISTED
Cymabay Therapeutics
CBAY
| $13M | 7.21% | 1,187,801 -441,663 | -27% | -$4.84M |
|
6
KalVista Pharmaceuticals
KALV
$678M
| $12.7M | 7.05% | 1,412,336 +290,354 | +26% | +$2.61M |
|
7
Biogen
BIIB
$19.4B
| $11.7M | 6.48% | 41,047 +3,588 | +10% | +$1.02M |
|
|
HZNP
8
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $10.2M | 5.68% | 99,495 +278 | +0.3% | +$28.6K |
|
9
Apellis Pharmaceuticals
APLS
$3.48B
| $9.78M | 5.43% | 107,406 -15,759 | -13% | -$1.44M |
|
|
MORF
10
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $8.73M | 4.84% | 152,360 -94,256 | -38% | -$5.4M |
|
11
iTeos Therapeutics
ITOS
$449M
| $8.42M | 4.67% | 636,158 +155,505 | +32% | +$2.06M |
|
|
12
BioMarin Pharmaceuticals
BMRN
$11.2B
| $8.03M | 4.45% | +92,626 | New | +$8.03M |
|
13
Ascendis Pharma
ASND
$11.8B
| $7M | 3.88% | 78,442 +1,232 | +2% | +$110K |
|
14
BioCryst Pharmaceuticals
BCRX
$1.74B
| $6.72M | 3.73% | 954,856 -208,679 | -18% | -$1.47M |
|
|
15
Sarepta Therapeutics
SRPT
$1.78B
| $6.18M | 3.43% | +53,995 | New | +$6.18M |
|
|
16
Astria Therapeutics
ATXS
$349M
| $5.31M | 2.95% | 637,857 +536,518 | +529% | +$4.47M |
|
17
Syndax Pharmaceuticals
SNDX
$1.41B
| $3.64M | 2.02% | +173,717 | New | +$3.64M |
|
|
SAGE
18
DELISTED
Sage Therapeutics
SAGE
| $3.32M | 1.84% | 70,559 -74,459 | -51% | -$3.5M |
|
19
argenx
ARGX
$43.6B
| $1.59M | 0.88% | +4,081 | New | +$1.59M |
|
20
Scilex Holding
SCLX
$124M
| $57.9K | 0.03% | 10,390 | – | – |
|
|
21
Amicus Therapeutics
FOLD
$2.34B
| – | – | -258,288 | Closed | -$2.86M |
|
|
TSVT
22
DELISTED
2seventy bio
TSVT
| – | – | -172,188 | Closed | -$1.76M |
|
|
23
Arcutis Biotherapeutics
ARQT
$1.86B
| – | – | -178,217 | Closed | -$1.96M |
|